For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

Bioresponse, LLC

USPTO Granted Patents = 25

% Expired Patents = 32.0

CIPO Patents = 8

EPO Patents = 3

Trademarks = 11

Forward Citations = 421

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Michael A Zeligs (18 out of 23 patents)

Irwin C Jacobs (6 out of 17 patents)

Sam Rose (5 out of 8 patents)

4. Robert V Oakley (1 out of 14 patents)

5. James F Long (1 out of 2 patents)

6. Rudolpf F Bliem (1 out of 1 patent)

7. Elaine L Wilson (1 out of 2 patents)

8. Van C Taiariol (1 out of 5 patents)

9. Rudolf F Bliem (4 patents)

10. Roland Varecka (1 patent)

11. Glenn C Buchanan (3 patents)

12. Peter Ventura (0 patent)

Core Competencies:

Self-Emulsifying Formulations

Diindolylmethane

Anti-Parasitic Methods

Phytochemicals

Cervical Dysplasia

Respiratory Syncytial Virus

Controlled-Release Alkaloids

Steroid Hormone Metabolism

Cell Culture Techniques

Weight Loss

HPV Treatment

Leiomyomas

25 patents: Sort by Forward Citations

1. 11337961 - Self-emulsifying formulations of DIM-related indoles (2022-05-24),

2. 10799479 - Self-emulsifying formulations of DIM-related indoles (2020-10-13),

3. 10441569 - Self-emulsifying formulations of DIM-related indoles (2019-10-15),

4. 9918965 - Self-emulsifying formulations of DIM-related indoles (2018-03-20),

5. 9663462 - Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles (2017-05-30),

6. 9353058 - Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles (2016-05-31),

7. 8552052 - Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions (2013-10-08),

8. 8236848 - Diindolylmethane for the treatment of HPV infection (2012-08-07),

9. 8080577 - Diindolylmethane formulations for the treatment of leiomyomas (2011-12-20),

10. 7989486 - Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions (2011-08-02),

11. 7384972 - Phytochemicals for treatment of endometriosis (2008-06-10),

12. 7384971 - Phytochemicals for the treatment of cervical dysplasia (2008-06-10),

13. 7348352 - Diindolylmethane for the treatment of HPV infection (2008-03-25),

14. 6689387 - Phytochemicals for treatment of mastalgia and endometriosis (2004-02-10),

15. 6534085 - Phytochemicals for promoting weight loss (2003-03-18),

Company Overview

Bioresponse, LLC is a biotechnology company based in Boulder, Colorado, specializing in the development and manufacturing of innovative biopharmaceutical products. The organization focuses on harnessing advanced biological processes to create solutions that address unmet medical needs. With a commitment to research and development, Bioresponse aims to enhance therapeutic options across various medical domains, leveraging cutting-edge technology to improve patient outcomes and advance the field of biomedicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

25 Patents

#55 in Boulder, CO

#266 in Colorado

#13,364 in US

#25,710 in the World

Boulder, CO, United States of America

Bioresponse, LLC

Forward Citations = 421

8 inventors:

Michael A Zeligs (18 out of 23 patents)

Irwin C Jacobs (6 out of 17 patents)

Sam Rose (5 out of 8 patents)

4. Robert V Oakley (1 out of 14 patents)

5. James F Long (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioresponse, LLC. Retrieved from https://idiyas.com/company/bioresponse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…